Insulin-dependent diabetes mellitus (IDDM) is a chronic autoimmune disease involving the selective destruction of the insulin-producing beta cells of the islets. Although a variety of host genetic factors contribute to disease susceptibility, progression to disease requires activated T cells. The relatively low frequency of IDDM may in part reflect that mature autoreactive T cells are normally subject to stringent immunoregulation. To gain information on the factors controlling immunoregulation, we propose to study the types of T-APC interactions that generate CD4+ T cells that have the ability to mediate IDDM in a murine transgenic model of disease. Our major goal is to test the hypothesis that the avidity of T-APC interactions plays a role in determining the outcome of mature T cell activation by directing the expression of accessory molecules on T cells and APC that influence the expression of particular effector functions.
In AIM 1, we will examine the extent to which antigen concentration and affinity of T-APC interactions dictate the expression of a variety of molecules regulating different aspects of T cell responses, e.g., costimulation, survival, homing.
In AIM 2, using both in vivo and in vitro models, we will define the role of antigen concentration and affinity in determining a) the cytokines produced by the effector T cells, b) the extent of the proliferative response, and c) the susceptibility of those T cells to tolerance.
In AIM 3, the influence of avidity in generating T cells that migrate to the pancreas and display destructive or protective effects on the islets will be determined. Collectively, the experiments will provide a comprehensive view of how the avidity of T-APC interactions can influence the generation of potential autoaggressive cells and define the particular steps between recognition of antigen and disease that are most sensitive to changes in avidity. The information gained from these studies may contribute to the development of both effective intervention strategies and strategies for monitoring the effectiveness of intervention.

Project Start
1999-06-01
Project End
2001-05-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Camacho, S A; Heath, W R; Carbone, F R et al. (2001) A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol 2:523-9
Ragazzo, J L; Ozaki, M E; Karlsson, L et al. (2001) Costimulation via lymphocyte function-associated antigen 1 in the absence of CD28 ligation promotes anergy of naive CD4+ T cells. Proc Natl Acad Sci U S A 98:241-6
Ozaki, M E; Webb, S R (2000) Controlling mature CD4+ T cell responses. Immunol Res 21:345-55
Nugent, C T; Morgan, D J; Biggs, J A et al. (2000) Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas. J Immunol 164:191-200
Kreuwel, H T; Morgan, D J; Krahl, T et al. (1999) Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. J Immunol 163:4335-41
Morgan, D J; Kreuwel, H T; Sherman, L A (1999) Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol 163:723-7
Morgan, D J; Kurts, C; Kreuwel, H T et al. (1999) Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A 96:3854-8
Ozaki, M E; Coren, B A; Huynh, T N et al. (1999) CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs. J Immunol 163:5250-6
Gallichan, W S; Balasa, B; Davies, J D et al. (1999) Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. J Immunol 163:1696-703
Gallichan, W S; Kafri, T; Krahl, T et al. (1998) Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 9:2717-26

Showing the most recent 10 out of 11 publications